about
Gabapentin or pregabalin for the prophylaxis of episodic migraine in adultsAnticonvulsant drugs for migraine prophylaxisThe effect of sodium valproate on chronic daily headache and its subgroupsPreventive pharmacologic treatments for episodic migraine in adultsEvidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache SocietyAnticonvulsant drugs for migraine prophylaxisThe optimal management of headaches in children and adolescentsImplementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin® litigationMigraine: diagnosis and managementAdvances in pharmacological treatment of migraineEFNS guideline on the drug treatment of migraine - report of an EFNS task forceDifferences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentinThe Relationship Between Headaches with Epileptic and Non-epileptic Seizures: a Narrative Review.Italian guidelines for primary headaches: 2012 revised versionProphylaxis of migraine headacheA2delta ligands gabapentin and pregabalin: future implications in daily clinical practice.A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.Antiepileptics in migraine prophylaxis: an updated Cochrane review.The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs.Antiepileptic drugs in migraine prevention.Chronic disorders with episodic manifestations: focus on epilepsy and migraine.Placebo response in the prophylaxis of migraine: a meta-analysis.Anticonvulsants in migraine prophylaxis: a Cochrane review.Migraine: preventive treatment.Chronic daily headaches in children.Emerging drugs in migraine treatment.Preventive treatment of migraine: effect on weight.Migraine treatment throughout the lifecycle.The acute and preventative treatment of episodic migraine.Migraine: new treatment options from molecular biology.Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproateNew drugs for migraineThe impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T ¹H-MRS studyMigraine: a review and future directions for treatment.Pharmacological management of mood and anxiety disorders in headache patients.Topiramate prophylaxis and response to triptan treatment for acute migraine.Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain.Preventive agents for migraine: focus on the antiepileptic drugs.Preventive treatment in migraine and the new US guidelinesRestoring invisible and abandoned trials: a call for people to publish the findings.
P2860
Q24201830-24814B23-3051-4A8C-84C5-04C76F43B2DAQ24246734-2A948A6B-D1FB-4AC7-A40D-9B5A8264DCA1Q24627574-2318F404-BE99-4E93-9DF7-581935E45ADBQ24630992-47F2587D-1FD1-4969-9653-CBDC868E8E72Q24633523-4201AB56-01F5-4434-938A-738B26D65369Q26471986-526EC97A-7336-41E0-8698-806FE3CF3A22Q26770813-4DA0AA53-5995-4CF6-9E87-5ECCB491BAA5Q27498844-E2AD8707-AED9-4079-AAA4-3D9565C1A436Q28165454-90B75F65-F27D-4093-BE77-E6790AAFB796Q28192002-3C24F5C9-3D12-4CBA-97CB-4DF85307B347Q28219436-8EBC465A-51C4-42F9-9294-F6B18F305E68Q28485343-F3230EA0-BB83-43CD-8B15-1ADAE4FA3F70Q30235393-280CBC8A-2F69-4B5E-955F-27B8559100E1Q30466790-4455ACBE-8944-4E69-AD60-AC59DE5E3155Q33794672-6CDAEEDB-5237-4698-9945-10C6B3FA4AAFQ33953965-62371DA1-990C-4394-BB8E-97FC4C1E51BFQ34003508-CD59A8B2-6B23-4C91-9E26-E7A815406225Q34433318-FCB0DA44-0C36-417F-9F89-4520EFFC0F66Q34525841-3EA35A26-9BDF-4BE4-86C0-EF2F7065AFEDQ34570667-7F0E9CC1-5531-4235-8E2D-75947A7CE4DFQ34590975-FAB87BA1-BDA3-4784-937D-7CC70F495F8DQ34621702-3938598B-1352-49A2-8159-9BB647D6658EQ34775712-EEF6DA7B-3DFB-42CB-A969-A549CE139BF4Q34852689-E68342B5-E445-432E-B500-FA77A777E6D5Q35095191-AA14187B-D428-41C6-8EED-B2E1FA6DF989Q35602660-C77E81E6-0C91-43FD-87A1-8B62487F947FQ35987931-1197CB6C-D761-4E3F-A14B-60CB62B8364AQ36153372-AA9B5CF5-6D2B-4AA5-8279-E424FF127A18Q36239483-06BE5EE7-80B6-46E9-A90D-34D5D98565D3Q36257220-3252E753-06CA-40FA-8C49-EF4CAA69990FQ36332568-7F224BA5-44A0-4511-90D9-CA5897ED5F7DQ36332611-4AFE75FB-96B2-4983-9608-68C4DEE6AD4DQ36403818-E251FCC7-4D7C-4294-983B-676B6B0131ADQ36546603-7D48EC88-CF38-4709-83F3-053D877B335DQ36620652-DF260925-C0AD-4E28-8666-9F624CF8E41FQ36623181-B1AB7DEE-DF4F-49D2-BEF4-617900AA83F4Q36697477-4DCBC657-0C6E-4171-8152-3FD4F8144595Q36748706-626BE799-FCDE-4829-8E0B-F6E4BCFD7543Q36873484-C5CC6D70-831A-4BD1-BFD9-2E33F49CBF4EQ36937327-05A614AB-249E-479D-8AE5-16C2FB6078CF
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Efficacy of gabapentin in migraine prophylaxis.
@ast
Efficacy of gabapentin in migraine prophylaxis.
@en
type
label
Efficacy of gabapentin in migraine prophylaxis.
@ast
Efficacy of gabapentin in migraine prophylaxis.
@en
prefLabel
Efficacy of gabapentin in migraine prophylaxis.
@ast
Efficacy of gabapentin in migraine prophylaxis.
@en
P2093
P2860
P1433
P1476
Efficacy of gabapentin in migraine prophylaxis.
@en
P2093
A Rapoport
N T Mathew
P2860
P304
P356
10.1046/J.1526-4610.2001.111006119.X
P577
2001-02-01T00:00:00Z